Skip to main content

Table 4 Medication use related to index hospitalization

From: The importance of having good quality indicators for care of patients with COPD: a look at hospital readmission rates

 

Total group

No hospitalization the year before the index hospitalization

 ≥ 1 hospitalization the year before the index hospitalization

 

Without re-admission (n = 466)

With re-admission (n = 737)

p-value

Without re-admission (n = 140)

With re-admission (n = 99)

p-value

Without re-admission (n = 326)

With re-admission (n = 638)

p-value

ICS use 6 months before index hospitalization (%)

16.1%

21.1%

0.03

10.7%

10.1%

0.87

18.4%

22.9%

0.11

ICS use 3 months after index hospitalization (%)

14.1%

17.8%

0.10

8.5%

10.1%

0.69

16.6%

19.0%

0.36

LAMA use 6 months before index hospitalization (%)

34.8%

48.4%

 < 0.0001

22.8%

26.3%

0.54

39.9%

51.9%

0.0004

LAMA use 3 months after index hospitalization (%)

36.9%

51.8%

 < 0.0001

28.6%

41.1%

0.04

40.5%

53.4%

0.0001

SABA use 6 months before index hospitalization (%)

42.3%%

49.8%

0.01

33.5%

43.4%

0.12

46.0%

50.8%

0.03

SABA use 3 months after index hospitalization (%)

43.5%

46.4%

0.33

36.4%

41.4%

0.43

46.6%

47.1%

0.87

LABA use 6 months before index hospitalization (%)

4.9%

6.6%

0.22

2.8%

3.0%

0.93

5.8%

7.2%

0.42

LABA use 3 months after index hospitalization (%)

5.4%

8.1%

0.07

6.4%

9.1%

0.44

4.9%

8.0%

0.07

  1. *Readmission within 90 days
  2. ICS Inhaled corticosteroids; LAMA long-acting muscarinic antagonist, SABA Short-acting beta agonist